Page last updated: 2024-12-07

sufoxazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6438129
SCHEMBL ID4075110
MeSH IDM0131877

Synonyms (18)

Synonym
y-8894 ,
teniloxazine maleate
sulfoxazine maleate
luceran
metatone
morpholine, 2-((2-(2-thienylmethyl)phenoxy)methyl)-, (z)-2-butenedioate (1:1)
sufoxazine
2-((2-(2-thienylmethyl)phenoxy)methyl)morpholine (z)-2-butenedioate (1:1)
(+-)-2-((o-(2-thenyl)phenoxy)methyl)morpholine maleate
62473-80-7
1by0cj6qwx ,
unii-1by0cj6qwx
SCHEMBL4075110
2-[2-(2-thenyl)phenoxymethyl]morpholine maleate
ONQAJVWRFPPADI-BTJKTKAUSA-N
teniloxazine maleate [jan]
Q27894394
(z)-but-2-enedioic acid;2-[[2-(thiophen-2-ylmethyl)phenoxy]methyl]morpholine

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" In cirrhotic patients, the pharmacokinetic parameters of teniloxazine remained essentially invariant with time."( The pharmacokinetics of teniloxazine in healthy subjects and patients with hepatic cirrhosis.
Benvenuti, C; Mazzo, M; Orlando, R; Palatini, P, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (76.92)18.7374
1990's3 (23.08)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]